Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1588)
•••
Post by Pandoraon Oct 24, 2020 7:08pm
200 Views
Post# 31777425

Sherri's dental patent

Sherri's dental patent

Sherri's dental patent continues to move along. Notice of allowance has been given and notice of fees due has been issued:

Select New Case Application Data Transaction History Image File Wrapper Continuity Data Published Documents Correspondence Data Supplemental Content Assignments Display Download References
 Transaction History
Mail Notice of Allowance
Date Transaction Description
10-20-2020 Electronic Review
10-20-2020 Email Notification
10-20-2020 Mail Notice of Allowance
16/264,737 Polygonum Cuspidatum Extracts As Photodynamic Inactivating Agents 206204-0001-01US Printer Friendly Version


Available Documents
Mail Room Date sort by Mail Room Date What is a Document Code Document Code sort by Document Code Document Description sort by Document Description What is a Document Code Document Category sort by Document Category Page Count sort by Page Count Download the selected documents as PDF
10-20-2020 NOA Notice of Allowance and Fees Due (PTOL-85) PROSECUTION 8
10-20-2020 INTV.SUM.APP Applicant Initiated Interview Summary (PTOL-413) PROSECUTION 2
10-20-2020 SRFW Search information including classification, databases and other search related notes PROSECUTION 1
10-20-2020 IIFW Issue Information including classification, examiner, name, claim, renumbering, etc. PROSECUTION 3
10-20-2020 BIB Bibliographic Data Sheet
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities